How deadly is Alzheimer?

Fuula kana dhaggeeffadhu

Dhukkubni Alzaayimeer hammam nama ajjeesa?

Dhukkubni Alzaayimeer dhukkubsataa sammuu kan taʼe siʼa taʼu, dhukkubni kun seelota sammuu akka mancaʼaniifi akka duʼan kan godhu siʼa taʼu, kunimmoo dandeettii yaadannoo, yaadaafi yaadaa hirʼisuuf isaan gargaara.

Dhukkubni kun sababa demensii baay'ee kan ta'e yoo ta'u, dhukkuboota hunda keessaa 60-80% kan ta'edha.

Dhukkubni kun dhumarratti du'a kan geessisu yoo ta'u, dhukkubni kun yoo mul'ate namoonni tokko tokko hanga waggaa 20tti jiraachuu kan danda'an yoo ta'u, متوسط umurii isaanii waggaa 4-8 ta'a.

Lakkoofsi du'a dhukkuba Alzaayimeerii qorannoo fi uummataa qoratamaa jiru irratti hundaa'uun garaagarummaa qaba.

Dhaabbanni Alzaayimeer jedhamu akka jedhetti, dhukkubni Alzaayimeer Yunaayitid Isteetis keessatti sababa du'a isa ja'affaa, akkasumas namoota umuriin isaanii waggaa 65 fi isaa ol ta'aniif sababa du'a isa shanaffaa ta'a.

Bara 2019tti, dhukkubni Alzaayimer sababa du'a namoota 121,9444 Yunaayitid Isteetis keessatti akka ta'e gabaafameera.

Lakkoofsi du'a dhukkuba Alzaayimeer sababa dhukkubichaa qofa osoo hin ta'in, sababa walqabatee fi dhimmoota fayyaa kan biroo sababa dhukkubichaatiin ka'an akka ta'e hubachuun barbaachisaadha.

Dhukkubni kun yeroo dabalaa adeemu, namoonni nyaata nyaachuu, dhiqachuufi uffata uffachuu wajjin haala wal qabateen rakkina qabaachuu dandaʼu. Kunimmoo hanqina nyaataa, dhukkubsannaafi rakkoowwan fayyaa kan biraa fiduu dandaʼa.

Kana malees, namoonni dhukkuba Alzaayimeer qaban, kufuu, dhukkuba sombaafi dhukkuboota kaanii argachuuf baayʼee saaxilamu.

Yeroo ammaa dhukkubni Alzaayimeer fayyuu kan hin dandeenye ta'us, mallattoowwan dhukkubichaa to'achuufis ta'e qulqullina jireenyaa fooyyessuuf gargaaruun ni danda'ama.

Qorannoowwan wal'aansa haaraa qopheessuufis ta'e dhumarratti dhukkuba hamaa kana fayyisuuf hojjetamaa jiru.

Ilaalchawwan

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.

Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.

Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.

Mortality from Alzheimer disease--United States, 1979-1987. MMWR Morb Mortal Wkly Rep. 1990, 39 (43): 785-8.

Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.

Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.

Ejjennoo: fayyaa

Weebsaayitiin kun kaayyoo barnootaa fi odeeffannoo qofaaf kan qophaa'e yoo ta'u, gorsa fayyaa ykn tajaajila ogummaa kennuu miti.

Odeeffannoon kenname kun rakkoo fayyaa ykn dhukkuba tokko adda baasuuf ykn wal'aanuuf itti fayyadamuu hin qabu, namoonni gorsa fayyaa dhuunfaa barbaadanis ogeessa fayyaa hayyama qabu wajjin mari'achuu qabu.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numerical content. For example, the number of people diagnosed with a specific disease.

Yeroo hunda waa'ee dhukkuba tokkoo gorsa ogeessa fayyaa ykn ogeessa fayyaa ga'eessa ta'e biraa gaafadhu. Gorsa fayyaa ogeessaa hin tuffatin ykn waan weebsaayitii kana irratti dubbisteef isa barbaaduu hin daangeffatin. Yoo rakkoo fayyaa qabaachuu dandeessan yoo ta'e, hatattamaan 911 bilbilaa ykn gara kutaa ariifachiisaa dhihoo deemaa. Weebsaayitii kana ykn itti fayyadama isaatiin hariiroon ogeessa fayyaa fi dhukkubsataa hin uumamu. BioMedLib ykn hojjettoonni isaa, ykn namni weebsaayitii kana irratti gumaache kamiyyuu, odeeffannoo asitti kenname ykn itti fayyadama isaa ilaalchisee ibsa ykn yaada hin kennine hin kennine.

Ejjennoo: Mirga bu'uuraa

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) abbootii seeraa meeshaaleen intarneetii irratti mul'atan mirga isaanii seera abbaa seerummaa Yunaayitid Isteetis jalatti cabsu jedhanii amanuuf furmaata ni kenna.

Qabiyyeen ykn meeshaan Weebsaayitii keenya ykn tajaajila keenya waliin walqabatee qophaa'e kamiyyuu mirga abbaa seerummaa keessan kan cabsu akka ta'e amanuu yoo barbaadde, ati (yommuu ta'u bakka bu'aa keessan) qabiyyeen ykn meeshaan kun akka kaafamu ykn akka dhorkamu nutti himachuu ni danda'a.

Beeksisni barreeffamaan ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa

DMCA'n beeksiinsi keessan waa'ee cabsaa seeraa kan himatamu odeeffannoo armaan gadii akka dabalatu gaafata: (1) ibsa hojii seeraa kan cabsaa seeraa kan himatamu ta'e; (2) ibsa qabiyyee cabsaa seeraa kan himatamu fi odeeffannoo qabiyyee isaa akka argannu nu dandeessisu ga'aa ta'e; (3) odeeffannoo wal qunnamtii keessan, kan akka teessoo keessan, lakkoofsa bilbilaa fi teessoo iimeelii keessan; (4) ibsi keessan qabiyyee akkaataa komatamanitti akka hin hayyamamne amantaa gaarii akka qabdan ibsa;

(5) beeksifannaa keessatti odeeffannoon sirrii akka ta'e fi mirgi abbaa qabeenyaa akka cabse kan himatamu akka ta'e labsii ati mallatteessite;

fi (6) mallattoo qaamaa ykn elektirooniksii abbaa seeraa ykn nama bakka bu'aa abbaa seeraa ta'uun akka hojjetu hayyamame.

Odeeffannoowwan armaan olitti tarreeffaman hunda kan hin dabalne yoo ta'e, dhimmi komii keessan akka hin mari'atamne gochuu danda'a.

Walitti dhufeenyi

Gaaffii / yaada kamirrayyuu qabdan nutti ergi.

How deadly is alzheimer?

Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.

It is the most common cause of dementia, accounting for 60-80% of all cases.

The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.

The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.

According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.

In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.

It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.

As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.

Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.

While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.

Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.